H4494

Prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program

Introduced·9/18/25
Introduced Text

Massachusetts H4494 prohibits pharmacy benefit managers from discriminating against hospitals and patients in the 340B drug discount program.

Massachusetts H4494 aims to protect hospitals and patients participating in the federal 340B drug discount program from unfair practices by pharmacy benefit managers (PBMs). The bill prohibits PBMs from imposing penalties, interfering with patient choices, or reimbursing 340B covered entities at lower rates than non-340B entities. It also bans PBMs from assessing fees, restricting network participation, requiring specific contracts, or imposing coverage limitations based on 340B participation. This legislation seeks to ensure equitable treatment for 340B program participants.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Health Care Financing Committee
Next
Committee decision

Sponsors

0
0
Democratic CaucusRepublican Caucus

History

Jun 17

House

Reporting date extended to Friday, July 31, 2026

Mar 19

House

Reporting date extended to Monday, June 15, 2026

Dec 8, 2025

House

Reporting date extended to Wednesday, March 18, 2026